In this report, Middle East and Africa hemostats market is projected to reach USD 134.3 million by 2024 from USD 103.7 million in 2016, growing at a CAGR of 3.2 % in the forecast period 2017 to 2024.
Based on geography, the Middle East and Africa hemostats market is segmented into 5 geographical regions, such as,

South Africa
Rest Of Middle East And Africa

Middle East and Africa hemostats market competition by top players including -
Pfizer,
C.R. Bard,
Baxter,
Vascular Solutions, Inc.,
B.Braun Melsungen,
Anika Therapeutics, Inc.,
CryoLife, Inc.,
Hemostasis, LLC,
Johnson & Johnson Services, Inc.,
MedTrade Products Limited.,
Integra LifeSciences Corporation,
HEMOTEC MEDICAL GMBH,
Stryker,
CSL Behring
Mallinckrodt Pharmaceuticals
?
The Middle East and Africa hemostats market is segmented on the basis of product type, application, end-user, distribution channel, and geography.

On the basis of product types the Middle East and Africa hemostats market is segmented into five product type which includes thrombin based hemostats, combination agents hemostats, oxidized regeneration cellulose based hemostats, gelatin based hemostats and collagen based segments.

On the basis of application, the Middle East and Africa hemostats market is segmented into wound closure and surgery. The surgery segment dominated the market in 2016.

On the basis of end users, the market is classified into hospitals, clinics, ambulatory centers, community healthcare and others.
On the basis of distribution channel, the Middle East and Africa hemostats market is segmented into direct tenders and